REMS Refinement: Does iPLEDGE’s Evolution Have Lessons For Opioids?
This article was originally published in The Pink Sheet Daily
Executive Summary
The Drug Safety and Risk Management and Dermatologic and Ophthalmic Drugs Advisory Committees will assess the risk management program Dec. 1 for lessons about implementing REMS containing elements to assure safe use and selecting assessment metrics.